Top

Published in:

01-11-2016 | Original Paper

Oxidative stress parameters in localized scleroderma patients

Authors: F. Kilinc, S. Sener, A. Akbaş, A. Metin, S. Kirbaş, S. Neselioglu, O. Erel

Published in: Archives of Dermatological Research | Issue 9/2016

Abstract

Localized scleroderma (LS) (morphea) is a chronic, inflammatory skin disease with unknown cause that progresses with sclerosis in the skin and/or subcutaneous tissues. Its pathogenesis is not completely understood. Oxidative stress is suggested to have a role in the pathogenesis of localized scleroderma. We have aimed to determine the relationship of morphea lesions with oxidative stress. The total oxidant capacity (TOC), total antioxidant capacity (TAC), paroxonase (PON) and arylesterase (ARES) activity parameters of PON 1 enzyme levels in the serum were investigated in 13 LS patients (generalized and plaque type) and 13 healthy controls. TOC values of the patient group were found higher than the TOC values of the control group (p < 0.01). ARES values of the patient group was found to be higher than the control group (p < 0.0001). OSI was significantly higher in the patient group when compared to the control (p < 0.005). Oxidative stress seems to be effective in the pathogenesis. ARES levels have increased in morphea patients regarding to the oxidative stress and its reduction. Further controlled studies are required in wider series.

Abraham D, Distler O (2007) How does endothelial cell injury start? The role of endothelin in systemic sclerosis. Arthritis Res Ther 9(2):2CrossRef

Akoglu G, Emre S, Metin A, Akbas A, Yorulmaz A, Isıkoglu S, Sener S, Kilinc F (2013) Evaluation of total oxidant and antioxidant status in localized and generalized vitiligo. Clin Exp Dermatol 38(7):701–706PubMed

Akoglu G, Metin A, Kilinc F, Pektas SD, Isıkoglu S, Akbas A, Sener S (2013) Total serum oxidant/antioxidant status and arylesterase activity in recurrent aphthous stomatitis. Ann Dermatol 25(3):273–277PubMedPubMedCentralCrossRef

Altindag O, Karakoc M, Soran N, Celik H, Celik N, Selek S (2007) Paraoxonase and arylesterase activities in patients with rheumatoid arthritis. Rheumatism 22:132–136

Arkachaisri T, Pino S (2008) Localized scleroderma severity index and global assessments: a pilot study of outcome instruments. J Rheumatol 35:650–657PubMedCrossRef

Aslan M, Horoz M, Nazlıgül Y, Bolukbas C, Bolukbas FF, Selek S, Aksoy N, Erel O (2008) Serum paraoxonase and arylesterase activities for the evaluation of patients with chronic hepatitis. Int J Clin Pract 62(7):1050–1055PubMedCrossRef

Badea I, Taylor M, Rosenberg A, Foldvari M (2009) Pathogenesis and therapeutic approaches for improved topical treatment in localized scleroderma and systemic sclerosis. Rheumatology 48(3):213–221PubMedCrossRef

Balbir-Gurman A, Braun-Moscovici Y, Livshitz V, Schapira D, Markovits D, Rozin A, Boikaner T, Nahir AM (2007) Antioxidant status after iloprost treatment in patients with Raynaud’s phenomenon secondary to systemic sclerosis. Clin Rheumatol 26(9):1517–1521PubMedCrossRef

Bozkurt M, Dag S, Oktayoglu P, Em S, Yuksel H, Caglayan M, Sariyildiz MA, Batmaz I, Ucar D, Nas K (2014) Serum prolidase enzyme activity and oxidative status in patients with scleroderma. Acta Medica Mediterranea 30:127–132

10.

Brocard A, Quereux G, Moyse D, Drone B (2010) Localized scleroderma and zinc: a pilot study. Eur J Dermatol 20(2):172–174PubMed

11.

Careta MF, Romiti R (2015) Localized scleroderma: clinical spectrum and therapeutic update. An Bras Dermatol 90(1):62–73PubMedPubMedCentralCrossRef

12.

Christen-Zaech S, Hakim MD, Afsar FS, Paller AS (2008) Pediatric morphea (localized scleroderma): review of 136 patients. J Am Acad Dermatol 59(3):385–396PubMedCrossRef

13.

Distler JH, Jungel A, Pileckyte M, Zwerina J, Michel BA, Gay RE, Kowal-Bielecka O, Matucci- Cerinic M, Schett G, Marti HH, Gay S, Distler O (2007) Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis. Arthritis Rheum 56(12):4203–4215PubMedCrossRef

14.

Eckerson HW, Wyte MC, La Du BN (1983) The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 35(6):1126–1138PubMedPubMedCentral

15.

Emre S, Metin A, Demirseren DD, Kilic S, Isıkoglu S, Erel O (2013) The relationship between oxidative stress, smoking and the clinical severity of psoriasis. JEADV 27(3):370–375

16.

Erel O (2004) A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37(4):277–285PubMedCrossRef

17.

Erel O (2005) A new automated colorimetric method for measuring total oxidant status. Clin Biochem 38(12):1103–1111PubMedCrossRef

18.

Gabrielli A, Svegliati S, Moroncini G, Amica D (2012) New insights into the role of oxidative stress in scleroderma fibrosis. Open Rheumatol J 6:87–95PubMedPubMedCentralCrossRef

19.

Gabrielli A, Svegliati S, Moroncini G, Pomponio G, Santillo M, Avvedimento EV (2008) Oxidative stress and the pathogenesis of scleroderma: the Murrell’s hypothesis revisited. Semin Immunopathol 30(3):329–337PubMedCrossRef

20.

Haagen L, Brock A (1992) A new automated method for phenotyping arylesterase (E.C.3.1.1.2.) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clin Biochem 30(7):391–395PubMed

21.

Harma M, Harma M, Erel O (2005) Measurement of the total antioxidant response in preeclampsia with a novel automated method. Eur J Obstet Gynecol Reprod Biol 118:47–51PubMedCrossRef

22.

Isik A, Ustundag B (2006) Paraoxonase and arylesterase levels in behcet’s disease. F U Sag Bil Tıp Derg 20:307–315

23.

Leitenberger JJ, Cayce RL, Haley RW, Adams-Huet B, Bergstresser PR, Jacobe HT (2009) Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases. Arch Dermatol 145(5):545–550PubMedPubMedCentralCrossRef

24.

Marasini M, Cugno M, Bassani C, Stanzani M, Bottasso B, Agostoni A (1992) Tissue-type plasminogen activator and Von Willebrand Factor plasma levels as marker of endothelial involvement in patients with Raynaud’s phenomenon. Int J Microcirc Clin Exp 11(4):375–382PubMed

25.

Peng SL, Fatenejad S, Craft J (1997) Scleroderma: a disease related to damaged proteins? Nat Med 3(3):276–278PubMedCrossRef

26.

Simonini G, Cerinic MM, Generini S, Zoppi M, Anichini M, Cesaretti C, Pignone A, Falcini F, Lotti T, Cagnoni M (1999) Oxidative stres in systemic sclerosis. Mol Cell Biochem 196(1–2):85–91PubMedCrossRef

27.

Takehara K, Sato S (2005) Localized scleroderma is an autoimmune disorder. Rheumatology 44:274–279PubMedCrossRef

28.

Tikly M, Channa K, Theodorou P, Glumian M (2006) Lipid peroxidation and trace elements in systemic sclerosis. Clin Rheumatol 25(3):320–324PubMedCrossRef

29.

Tikly M, Marshall SE, Haldar NA, Gulumian M, Wordsworth P, Welsh KI (2004) Oxygen free radical scavenger enzyme polymorphisms in systemic sclerosis. Free Radic Biol Med 36(11):1403–1407PubMedCrossRef

30.

Toker A, Kadı M, Yildirim AK, Aksoy H, Akcay F (2009) Serum lipid profile paraoxonase and arylesterase activities in psoriasis. Cell Biochem Funct 27(3):176–180PubMedCrossRef

31.

Tsou PS, Balogh B, Pinney AJ, Zakhem G, Lozier A, Amin MA, Stinson WA, Schiopu E, Khanna D, Fox DH, Koch AE (2014) Lipoic acid plays a role in scleroderma: insights obtained from scleroderma dermal fibroblasts. Arthritis Res Ther 16(5):411PubMedCrossRef

32.

Uysal S, Akyol S, Hasgul R, Armutcu F, Yigitoglu MR (2011) Çok yönlü bir enzim: Paraoksonaz. Yeni Tıp Dergisi 28(3):136–141

33.

Valančienė G, Jasaitienė D, Valiukevičienė S (2010) Pathogenesis and treatment modalities of localized scleroderma. Medicina (Kaunas) 46(10):649–656

34.

Vasquez R, Sendejo C, Jacobe H (2012) Morphea and other forms of scleroderma. Curr Opin Rheumatol 24(6):685–693PubMed

35.

Veale DJ, Kırk G, Mclaren M, Belchh JJ (1998) Clinical implications of soluble intercellular adhesion molecule-1 levels in systemic sclerosis. Br J Rheumatol 37(11):1227–1228PubMedCrossRef

36.

Yamamoto T, Nishioka K (2005) Cellular and molecular mechanisms of bleomycin-induced murine scleroderma: current update and future perspective. Exp Dermatol 14(2):81–95PubMedCrossRef

Title: Oxidative stress parameters in localized scleroderma patients
Authors: F. Kilinc
S. Sener
A. Akbaş
A. Metin
S. Kirbaş
S. Neselioglu
O. Erel
Publication date: 01-11-2016
Publisher: Springer Berlin Heidelberg
Published in: Archives of Dermatological Research / Issue 9/2016
Print ISSN: 0340-3696
Electronic ISSN: 1432-069X
DOI: https://doi.org/10.1007/s00403-016-1682-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Oxidative stress parameters in localized scleroderma patients

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 9/2016

Increased syndecan-4 expression in sera and skin of patients with atopic dermatitis

An association between newly diagnosed cutaneous T cell lymphoma and prior impetigo: a nested case–control study

iTRAQ-based quantitative proteomics of stratum corneum of dandruff scalp reveals new insights into its aetiology and similarities with atopic dermatitis

IL-4 and human skin mast cells revisited: reinforcement of a pro-allergic phenotype upon prolonged exposure

Estimated serum vitamin D status, vitamin D intake, and risk of incident alopecia areata among US women

Forearm hair density and risk of keratinocyte cancers in Australian adults